82.90
price up icon4.26%   3.39
pre-market  Vorhandelsmarkt:  82.71   -0.19   -0.23%
loading
Schlusskurs vom Vortag:
$79.51
Offen:
$80.09
24-Stunden-Volumen:
1.31M
Relative Volume:
1.25
Marktkapitalisierung:
$14.38B
Einnahmen:
$8.31B
Nettoeinkommen (Verlust:
$379.00M
KGV:
38.38
EPS:
2.16
Netto-Cashflow:
$385.00M
1W Leistung:
+9.57%
1M Leistung:
+13.70%
6M Leistung:
+13.94%
1J Leistung:
+19.06%
1-Tages-Spanne:
Value
$79.83
$83.53
1-Wochen-Bereich:
Value
$75.00
$83.53
52-Wochen-Spanne:
Value
$60.70
$85.92

Solventum Corp Stock (SOLV) Company Profile

Name
Firmenname
Solventum Corp
Name
Telefon
651-733-1110
Name
Adresse
C/O 3M COMPANY, ST. PAUL
Name
Mitarbeiter
22,000
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
SOLV's Discussions on Twitter

Vergleichen Sie SOLV mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Instruments & Supplies icon
SOLV
Solventum Corp
82.90 13.79B 8.31B 379.00M 385.00M 2.16
Medical Instruments & Supplies icon
ISRG
Intuitive Surgical Inc
561.61 195.76B 9.61B 2.77B 2.27B 7.555
Medical Instruments & Supplies icon
BDX
Becton Dickinson Co
192.72 54.34B 21.84B 1.68B 2.67B 5.8322
Medical Instruments & Supplies icon
ALC
Alcon Inc
76.61 36.86B 10.19B 1.05B 1.38B 2.1044
Medical Instruments & Supplies icon
RMD
Resmed Inc
250.75 35.60B 5.26B 1.44B 1.76B 9.7713
Medical Instruments & Supplies icon
WST
West Pharmaceutical Services Inc
271.07 18.54B 2.96B 487.70M 344.00M 6.6758

Solventum Corp Stock (SOLV) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-10-01 Eingeleitet UBS Neutral
2025-09-11 Eingeleitet Jefferies Hold
2025-07-15 Hochstufung Morgan Stanley Equal-Weight → Overweight
2025-07-01 Hochstufung Argus Hold → Buy
2025-06-06 Eingeleitet KeyBanc Capital Markets Sector Weight
2025-05-19 Hochstufung Piper Sandler Neutral → Overweight
2024-12-04 Eingeleitet Mizuho Neutral
2024-10-08 Eingeleitet Stifel Buy
2024-10-07 Eingeleitet Piper Sandler Neutral
2024-09-26 Eingeleitet Wolfe Research Peer Perform
2024-09-05 Eingeleitet BTIG Research Neutral
2024-06-24 Eingeleitet Argus Hold
2024-05-30 Eingeleitet Goldman Sell
2024-05-10 Eingeleitet BofA Securities Neutral
2024-04-10 Eingeleitet Morgan Stanley Equal-Weight
2024-04-08 Eingeleitet Wells Fargo Equal Weight
2024-04-02 Eingeleitet Edward Jones Hold
Alle ansehen

Solventum Corp Aktie (SOLV) Neueste Nachrichten

pulisher
06:06 AM

Solventum to Acquire Acera Surgical in $725 Mn Deal to Boost Regenerative Wound-Care Portfolio - Digital Health News

06:06 AM
pulisher
02:43 AM

Solventum: Setting Up For Growth And A Re-Rating (NYSE:SOLV) - Seeking Alpha

02:43 AM
pulisher
Nov 23, 2025

Solventum to buy private wound care firm Acera for up to $850M - MSN

Nov 23, 2025
pulisher
Nov 22, 2025

Solventum To Buy Acera Surgical In $850 Million Deal To Expand Advanced Wound Care Portfolio - Pulse 2.0

Nov 22, 2025
pulisher
Nov 21, 2025

Solventum stock rating reiterated by UBS, Acera deal fills wound care gap - Investing.com South Africa

Nov 21, 2025
pulisher
Nov 21, 2025

Teleflex, Solventum, Haemonetics, Centene, and Molina Healthcare Shares Skyrocket, What You Need To Know - Yahoo Finance

Nov 21, 2025
pulisher
Nov 21, 2025

Solventum Corporation Reports Strong Q3 2025 Results - MSN

Nov 21, 2025
pulisher
Nov 21, 2025

Solventum Stock Gets Relative Strength Rating Lift - Investor's Business Daily

Nov 21, 2025
pulisher
Nov 21, 2025

A Look at Solventum’s Valuation Following $1 Billion Share Buyback Authorization - simplywall.st

Nov 21, 2025
pulisher
Nov 21, 2025

Acera Surgical, born from WashU research, to be acquired for up to $850M - The Business Journals

Nov 21, 2025
pulisher
Nov 21, 2025

Agree To Buy Solventum At $70, Earn 6.6% Annualized Using Options - Nasdaq

Nov 21, 2025
pulisher
Nov 21, 2025

Solventum inks $725M Acera takeover - MedTech Dive

Nov 21, 2025
pulisher
Nov 21, 2025

Solventum Trying To Close In On Key Technical Measure - MSN

Nov 21, 2025
pulisher
Nov 21, 2025

Solventum stock rating reiterated by UBS, Acera deal fills wound care gap By Investing.com - Investing.com Nigeria

Nov 21, 2025
pulisher
Nov 21, 2025

Solventum agrees to buy regenerative wound care maker Acera Surgical for $725M+ - The Business Journals

Nov 21, 2025
pulisher
Nov 21, 2025

How institutional buying supports Solventum Corporation stock2025 Earnings Impact & Safe Capital Allocation Plans - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Solventum Corporation: Hold Rating Amid Strategic Moves and Growth Challenges - TipRanks

Nov 21, 2025
pulisher
Nov 21, 2025

Solventum to acquire Acera Surgical - Medical Buyer

Nov 21, 2025
pulisher
Nov 21, 2025

How Solventum Corporation stock behaves in tightening cyclesBear Alert & AI Powered Buy and Sell Recommendations - newser.com

Nov 21, 2025
pulisher
Nov 20, 2025

Strategic Acquisition and Capital Management Propel Solventum Corporation’s Growth Potential - TipRanks

Nov 20, 2025
pulisher
Nov 20, 2025

Solventum announces $1 billion share repurchase program By Investing.com - Investing.com Nigeria

Nov 20, 2025
pulisher
Nov 20, 2025

Solventum Corp. stock rises Thursday, outperforms market - MarketWatch

Nov 20, 2025
pulisher
Nov 20, 2025

Solventum stock rises on $1 billion share buyback, Acera acquisition By Investing.com - Investing.com Nigeria

Nov 20, 2025
pulisher
Nov 20, 2025

Solventum stock rises on $1 billion share buyback, Acera acquisition - Investing.com

Nov 20, 2025
pulisher
Nov 20, 2025

Solventum to Acquire Acera Surgical for $850M - Medical Device and Diagnostic industry

Nov 20, 2025
pulisher
Nov 20, 2025

Solventum to acquire soft tissue repair company Acera Surgical, repurchase $1B in shares - MassDevice

Nov 20, 2025
pulisher
Nov 20, 2025

Solventum Corporation entered into a definitive agreement to acquire Acera Surgical, Inc. for $850 million. - MarketScreener

Nov 20, 2025
pulisher
Nov 20, 2025

Solventum agrees to acquire Acera for up to $850M - BioWorld MedTech

Nov 20, 2025
pulisher
Nov 20, 2025

Solventum to Buy Soft Tissue Repair Company Acera Surgical for up to $850M - Medical Product Outsourcing

Nov 20, 2025
pulisher
Nov 20, 2025

Solventum to Buy Acera Surgical; Approves $1 Billion Share Repurchase Program - MarketScreener

Nov 20, 2025
pulisher
Nov 20, 2025

Why Solventum Corporation Shares Are Climbing - TipRanks

Nov 20, 2025
pulisher
Nov 20, 2025

Solventum to acquire Acera Surgical for $725 million - Investing.com

Nov 20, 2025
pulisher
Nov 20, 2025

Solventum sets $1 billion share repurchase program - MSN

Nov 20, 2025
pulisher
Nov 20, 2025

Solventum To Acquire Privately-held Acera Surgical For Up To $850 Mln - Nasdaq

Nov 20, 2025
pulisher
Nov 20, 2025

Solventum to buy private wound care firm Acera (SOLV:NYSE) - Seeking Alpha

Nov 20, 2025
pulisher
Nov 20, 2025

Solventum announces agreement to acquire Acera Surgical - MarketScreener

Nov 20, 2025
pulisher
Nov 20, 2025

Solventum announces $1 billion share repurchase program - MarketScreener

Nov 20, 2025
pulisher
Nov 20, 2025

Solventum to buy Acera Surgical for up to $850 million - MarketScreener

Nov 20, 2025
pulisher
Nov 20, 2025

BRIEF-Solventum Announces Agreement To Acquire Acera Surgical - Devdiscourse

Nov 20, 2025
pulisher
Nov 20, 2025

Solventum Announces $1 Billion Share Repurchase Program - PR Newswire

Nov 20, 2025
pulisher
Nov 20, 2025

Why Solventum Corporation (KB7) stock fits value portfoliosWeekly Trend Summary & Smart Money Movement Alerts - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Why Solventum Corporation (KB7) stock trades below fair valueTreasury Yields & Real-Time Volume Triggers - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Can Solventum Corporation (KB7) stock sustain breakout momentum2025 Stock Rankings & Real-Time Chart Breakout Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Solventum Corporation authorizes a Buyback Plan. - MarketScreener

Nov 19, 2025
pulisher
Nov 19, 2025

Published on: 2025-11-19 16:31:11 - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Why Solventum Corporation stock stays resilientDay Trade & Stepwise Swing Trade Plans - newser.com

Nov 19, 2025

Finanzdaten der Solventum Corp-Aktie (SOLV)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
medical_instruments_supplies COO
$75.47
price up icon 6.13%
$74.36
price up icon 0.32%
$142.56
price up icon 7.34%
medical_instruments_supplies BAX
$18.31
price up icon 5.11%
medical_instruments_supplies WST
$271.07
price up icon 5.16%
Kapitalisierung:     |  Volumen (24h):